| Financial Year |
March 31 2023 |
| Monetary Funds |
3,219,369,124.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
496,075,486.64 |
| Accounts Receivable |
9,735,357,732.53 |
| Advances to Suppliers |
325,230,232.08 |
| Other Receivables |
360,479,191.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
42,187.13 |
| Dividend Receivable |
-- |
| Inventories |
2,882,859,098.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
507,919,511.81 |
| Other Current Assets |
198,247,685.01 |
| Total Current Assets |
18,614,474,797.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,109,723,858.28 |
| Long-term Equity Investment |
1,108,777,527.15 |
| Investment Properties |
182,297,924.92 |
| Fixed Assetes |
2,549,974,281.16 |
| Under-construction Projects |
778,674,599.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,581,488,897.09 |
| R&D expenses |
915,924,137.47 |
| Goodwill |
1,142,558,449.53 |
| Long-Term Deferred and Prepaid Expenses |
152,908,066.58 |
| Deferred Income Tax Assets |
1,405,512,389.70 |
| Other Non-Current Assets |
8,301,305.96 |
| Sub-Total of Non-Current Assets |
13,100,700,906.25 |
| Total Assets |
31,715,175,704.12 |
| Short-Term Loans |
364,011,982.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,271,865,623.31 |
| Accounts Payable |
4,068,848,132.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
129,950,247.82 |
| Taxes Payable |
208,213,715.04 |
| Interest Payable |
-- |
| Dividend Payable |
63,000,000.00 |
| Other payables |
1,132,366,946.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
682,499,296.36 |
| Other Current Liabilities |
469,936,199.59 |
| Sub-Total of Current Liabilities |
10,413,671,807.58 |
| Long-term Loans |
2,279,519,294.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,038,227,821.05 |
| Deferred Income Tax Liabilities |
193,626,394.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,559,954,531.91 |
| Total Liabilities |
14,973,626,339.49 |
| Paid-In Capital(Or Share Stock) |
2,323,084,333.00 |
| Capital Surplus |
10,039,723,056.61 |
| Surplus Reserve |
414,858,166.24 |
| LESS:Treasury Stock |
1,383,432,084.80 |
| Undistributed Profits |
4,954,442,368.60 |
| Minority Stockholder's Interest |
392,063,229.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,349,486,135.53 |
| Owner's Equity（Stockholder's Equity） |
16,741,549,364.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,715,175,704.12 |
